Vereide et al. revealed that miR-BART1 and miR-BART16 help to block apoptosis in BL cells in the absence of other viral oncogenes through their targeting of caspase 3 (Casp3) [31]. This evidence concerns the gene CASP3 and Burkitt lymphoma.